Trials / Completed
CompletedNCT01199510
Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness of FID 112903 (SYSTANE ULTRA® Lubricating Drops) plus standard of care to standard of care alone, in subjects with a history of intermittent eye irritation or dryness related to environmental factors and scheduled for routine cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FID 112903 (SYSTANE® ULTRA Lubricant Eye Drops) plus standard of care | Patients will dose 4 times daily for 30 days with FID 112903 and follow routine standard of care post-operatively |
| OTHER | Standard of Care | Post Cataract Surgery Standard of Care |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-09-13
- Last updated
- 2016-11-18
Source: ClinicalTrials.gov record NCT01199510. Inclusion in this directory is not an endorsement.